- Home
- ORIC vs VREX Comparison
ORIC vs VREX Comparison
Compare ORIC & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- VREX
- Stock Information
- Founded
- ORIC 2014
- VREX 2016
- Country
- ORIC United States
- VREX United States
- Employees
- ORIC N/A
- VREX 2300
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- ORIC Health Care
- VREX Technology
- Exchange
- ORIC Nasdaq
- VREX Nasdaq
- Market Cap
- ORIC 735.3M
- VREX 576.8M
- IPO Year
- ORIC 2020
- VREX N/A
- Fundamental
- Price
- ORIC $10.84
- VREX $14.15
- Analyst Decision
- ORIC Strong Buy
- VREX Strong Buy
- Analyst Count
- ORIC 9
- VREX 1
- Target Price
- ORIC $18.75
- VREX $21.00
- AVG Volume (30 Days)
- ORIC 825.1K
- VREX 377.8K
- Earning Date
- ORIC 03-10-2025
- VREX 02-06-2025
- Dividend Yield
- ORIC N/A
- VREX N/A
- EPS Growth
- ORIC N/A
- VREX N/A
- EPS
- ORIC N/A
- VREX N/A
- Revenue
- ORIC N/A
- VREX $811,000,000.00
- Revenue This Year
- ORIC N/A
- VREX $3.50
- Revenue Next Year
- ORIC N/A
- VREX $3.37
- P/E Ratio
- ORIC N/A
- VREX N/A
- Revenue Growth
- ORIC N/A
- VREX N/A
- 52 Week Low
- ORIC $6.33
- VREX $10.19
- 52 Week High
- ORIC $16.65
- VREX $19.91
- Technical
- Relative Strength Index (RSI)
- ORIC 52.90
- VREX 43.34
- Support Level
- ORIC $9.92
- VREX $13.35
- Resistance Level
- ORIC $12.00
- VREX $14.08
- Average True Range (ATR)
- ORIC 0.90
- VREX 0.41
- MACD
- ORIC 0.04
- VREX 0.03
- Stochastic Oscillator
- ORIC 41.82
- VREX 23.89
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.